In Vivo Determination of Muscarinic Acetylcholine Receptor Availability in Schizophrenia
Thomas J. Raedler(National Institutes of Health), Daniel R. Weinberger(Johns Hopkins University), Richard Coppola(United States Department of Health and Human Services), Julia G. Gorey, Michael Egan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Michael B. Knable, Douglas W. Jones(University of Massachusetts Chan Medical School), Richard A Urbina(National Institutes of Health), Kan S. Lee
Cited by 217
Related Papers
Schizophrenia
|Nature Reviews Disease Primers|2015|1.1k
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
|Brain|2009|962
Guidelines for the recording and quantitative analysis of electroencephalographic activity in research contexts
|Psychophysiology|1993|687
Executive Subprocesses in Working Memory
|Archives of General Psychiatry|2003|585